Literature DB >> 23169589

Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response.

Hannah P Gideon1, Katalin A Wilkinson, Tige R Rustad, Tolu Oni, Heinner Guio, David R Sherman, H Martin Vordermeier, Brian D Robertson, Douglas B Young, Robert J Wilkinson.   

Abstract

We analyzed whole genome-based transcriptional profiles of Mycobacterium tuberculosis subjected to prolonged hypoxia to guide the discovery of novel potential Ags, by a combined bioinformatic and empirical approach. We analyzed the fold induction of the 100 most highly induced genes at 7 d of hypoxia, as well as transcript abundance, peptide-binding prediction (ProPred) adjusted for population-specific MHC class II allele frequency, and by literature search. Twenty-six candidate genes were selected by this bioinformatic approach and evaluated empirically using IFN-γ and IL-2 ELISPOT using immunodominant Ags (Acr-1, CFP-10, ESAT-6) as references. Twenty-three of twenty-six proteins induced an IFN-γ response in PBMCs of persons with active or latent tuberculosis. Five novel immunodominant proteins-Rv1957, Rv1954c, Rv1955, Rv2022c, and Rv1471-were identified that induced responses similar to CFP-10 and ESAT-6 in both magnitude and frequency. IL-2 responses were of lower magnitude than were those of IFN-γ. Only moderate evidence of infection stage-specific recognition of Ags was observed. Reconciliation of bioinformatic and empirical hierarchies of immunodominance revealed that Ags could be predicted, providing transcriptomic data were combined with peptide-binding prediction adjusted by population-specific MHC class II allele frequency.

Entities:  

Mesh:

Year:  2012        PMID: 23169589      PMCID: PMC3519923          DOI: 10.4049/jimmunol.1202281

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.

Authors:  Helena I M Boshoff; Timothy G Myers; Brent R Copp; Michael R McNeil; Michael A Wilson; Clifton E Barry
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

Review 2.  Prokaryotic toxin-antitoxin stress response loci.

Authors:  Kenn Gerdes; Susanne K Christensen; Anders Løbner-Olesen
Journal:  Nat Rev Microbiol       Date:  2005-05       Impact factor: 60.633

3.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.

Authors:  Alexander S Pym; Priscille Brodin; Roland Brosch; Michel Huerre; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

4.  Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load.

Authors:  Kerry A Millington; John A Innes; Sarah Hackforth; Timothy S C Hinks; Jonathan J Deeks; Davinder P S Dosanjh; Valerie Guyot-Revol; Rubamalaar Gunatheesan; Paul Klenerman; Ajit Lalvani
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex.

Authors:  Ben Sidders; Chris Pirson; Philip J Hogarth; R Glyn Hewinson; Neil G Stoker; H Martin Vordermeier; Katie Ewer
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

6.  Killing activity and rescue function of genome-wide toxin-antitoxin loci of Mycobacterium tuberculosis.

Authors:  Amita Gupta
Journal:  FEMS Microbiol Lett       Date:  2008-11-10       Impact factor: 2.742

7.  Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.

Authors:  Lanbo Shi; Yu-Jin Jung; Sanjay Tyagi; Maria Laura Gennaro; Robert J North
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-27       Impact factor: 11.205

8.  Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Authors:  Gillian F Black; Bonnie A Thiel; Martin O Ota; Shreemanta K Parida; Richard Adegbola; W Henry Boom; Hazel M Dockrell; Kees L M C Franken; Annemiek H Friggen; Philip C Hill; Michel R Klein; Maeve K Lalor; Harriet Mayanja; Gary Schoolnik; Kim Stanley; Karin Weldingh; Stefan H E Kaufmann; Gerhard Walzl; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

9.  Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution.

Authors:  Holly R Ramage; Lynn E Connolly; Jeffery S Cox
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

Review 10.  Tuberculosis.

Authors:  Gary Maartens; Robert J Wilkinson
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321

View more
  15 in total

1.  Identification of Conserved Peptides Comprising Multiple T Cell Epitopes of Matrix 1 Protein in H1N1 Influenza Virus.

Authors:  Neha Lohia; Manoj Baranwal
Journal:  Viral Immunol       Date:  2015-09-23       Impact factor: 2.257

2.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

Review 3.  Recent advances in the development of vaccines for tuberculosis.

Authors:  Mohamed Jawed Ahsan
Journal:  Ther Adv Vaccines       Date:  2015-05

4.  Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis.

Authors:  Gareth J Jones; Bhagwati L Khatri; M Carmen Garcia-Pelayo; Daryan A Kaveh; Véronique S Bachy; Philip J Hogarth; Esen Wooff; Paul Golby; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2013-08-28

5.  Evaluation of cocktails with recombinant proteins of Mycobacterium bovis for a specific diagnosis of bovine tuberculosis.

Authors:  María Laura Mon; Roberto Damián Moyano; Mariana Noelia Viale; María Alejandra Colombatti Olivieri; Ignacio José Gamietea; Valeria Noely Montenegro; Bernardo Alonso; María de la Paz Santangelo; Mahavir Singh; Rosario Duran; María Isabel Romano
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

Review 6.  Latent Tuberculosis: Models, Computational Efforts and the Pathogen's Regulatory Mechanisms during Dormancy.

Authors:  Gesham Magombedze; David Dowdy; Nicola Mulder
Journal:  Front Bioeng Biotechnol       Date:  2013-08-27

7.  Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis.

Authors:  Martha Torres; Lourdes García-García; Pablo Cruz-Hervert; Heinner Guio; Claudia Carranza; Leticia Ferreyra-Reyes; Sergio Canizales; Susana Molina; Elizabeth Ferreira-Guerrero; Norma Téllez; Rogelio Montero-Campos; Guadalupe Delgado-Sánchez; Norma Mongua-Rodriguez; Jose Sifuentes-Osornio; Alfredo Ponce-de Leon; Eduardo Sada; Douglas B Young; Robert J Wilkinson
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

8.  A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.

Authors:  Wendy E Whatney; Neel R Gandhi; Cecilia S Lindestam Arlehamn; Azhar Nizam; Hao Wu; Melanie J Quezada; Angela Campbell; Salim Allana; Mbuyi Madeleine Kabongo; Jeremiah Khayumbi; Benson Muchiri; Joshua Ongalo; Joan Tonui; Loren E Sasser; Tawania J Fergus; Gregory Sadat Ouma; Samuel Gurrion Ouma; Allison A Beck; Mark J Mulligan; Alawode Oladele; Deepak Kaushal; Kevin P Cain; Lance Waller; Henry M Blumberg; John D Altman; Joel D Ernst; Jyothi Rengarajan; Cheryl L Day
Journal:  J Immunol       Date:  2018-03-14       Impact factor: 5.426

9.  ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.

Authors:  Truc Hoang; Claus Aagaard; Jes Dietrich; Joseph P Cassidy; Gregory Dolganov; Gary K Schoolnik; Carina Vingsbo Lundberg; Else Marie Agger; Peter Andersen
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

10.  Population tailored modification of tuberculosis specific interferon-gamma release assay.

Authors:  Kata Horvati; Szilvia Bősze; Hannah P Gideon; Bernadett Bacsa; Tamás G Szabó; Rene Goliath; Molebogeng X Rangaka; Ferenc Hudecz; Robert J Wilkinson; Katalin A Wilkinson
Journal:  J Infect       Date:  2015-11-26       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.